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such compounds has been described in
infants (3) and in offspring of rhesus mon-
keys (4), as exemplified by 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD). For
example, the half-life for nonmetabolic
elimination ofTCDD has been calculated
to be 0.42 years in newborns, which is sub-
stantially shorter than in adults (3). From
TCDD data collected over more than 15
years following the Seveso incident (5), it is
obvious that the half-life is shorter in infants
and increases significantly with age.
Although the amount ofTCDD in the
organism is a function ofuptake and elimi-
nation, the resulting tissue concentrations
are also functions of the body and tissue
volumes. The fast growth in the first years
of life leads to a "thinning" of the TCDD
tissue concentrations (3,6). Although the
relatively fast half-life, together with the
"thinning" effect, are insufficient to prevent
an increase ofTCDD tissue concentrations
during nursing, after weaning, both growth-
related dilution and elimination from the
body result in a fast decrease in these con-
centrations. In fact, TCDD concentrations
in tissues of babies breast-fed for up to 6
months can reach values in the lower range
of adults, but the concentrations decline
rather quickly, reaching values comparable
to nonbreast-fed children at about 5 years of
age (3). Importantly, these results are based
on general assumptions related to the class
ofcompounds described as lipophilic, non-
water soluble, nonvolatile, nonprotein
bound, and either slowly metabolized or not
metabolized; therefore, these results should
be valid not only for TCDD but for all
compounds meeting this description (3).
In conclusion, based on the current sci-
entific literature, even relatively high TCDD
concentrations that might be reached after 6
months ofnursing do not appear to lead to a
raised lifetimevalue. Comparing intake from
breast-feeding with cumulative long-term
intake may result in misleading perceptions
about health risks associated with intake of
TCDD and congeners.
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Patandin's Response
We would like to respond to LaKind and
Filser's comments about our paper that
was published in EHP(1).
LaKind and Filser emphasized that tis-
sue concentrations of TCDD and related
compounds are important when assessing
potential adverse effects, rather than assess-
ing long-term dietary intake only. We
agree with them; however, long-term
dietary intake is an important part ofexpo-
sure assessment. In our paper we mainly
focused on the polychlorinated biphenyl
(PCB) and dioxin (polychlorinated diben-
zodioxin and furan; PCDD/PCDF) intake
during different periods in life. Over 90%
ofexposure to PCBs and dioxins in the gen-
eral population is from oral intake. We
compared the intake of toxic equivalents
(TEQs) during breast-feeding (0-1 year of
age), after weaning (e.g., preschool years;
1-5 years of age), and until adulthood
(6-25 years ofage). We also calculated the
amount (percentage) of PCB/dioxin TEQ
intake during a 6-month period of breast-
feeding and its effect on the total cumula-
tive intake until adulthood (25 years).
Although some model calculations of
PCB/dioxin body burden and infant expo-
sure through breast milk have been pub-
lished (2,3), the cumulated PCB/dioxin
intake from infancy until adulthood had not
been quantitatively assessed. The cumulated
intake as calculated in this study is not iden-
tical to body burden because losses by excre-
tion and metabolism by the liver, as well as
different half-lives of different PCB and
dioxin congeners, are not taken into account
(1). We calculated the total mean intake of
PCBs/dioxins over a 25-year period in sub-
jects who were either formula-fed or breast-
fed for 3 and 6 months duringinfancy.
LaKind and Filser emphasized the thin-
ning effect in infants during growth and
the shorter half-lives reported for TCDD in
infants. The dilution effect of PCBs and
dioxins in the growing infant is a known
phenomenon (4,5). This dilution effect is
also found in older adults when the increase
ofPCB/dioxin tissue concentration is lower
than expected because of the increase of
total body fatwith age (2).
In aprevious publication (6), we present-
ed the sum PCB levels (IUPAC numbers
118, 138, 153, and 180) measured in the
plasma of42-month-old children who were
eitherbreast-fed orformula-fedduringinfan-
cy. The PCB levels measured at 42 months
ofage were strongly related (r= 0.63) to the
period ofbreast-feeding and negatively asso-
ciated with total body fat (percentage) and
body weight. Preschool children who were
breast-fed as infants have PCB body burdens
that are primarily dictated bytheir lactational
PCB exposures. The negative relationship
with plasma PCB concentration and body
fat percentage is most likely explained by the
fact that PCBs and related compounds are
distributed over all fat-containing compo-
nents in the body, especially adipose tissue
(diluted). Given a higher growth rate as well
as this dilution effect, a shorter half-life has
been reported for PCBs and dioxins in
young children (4,5). Despite this rapid
growth and shorter half-life, breast-fed
infants reach PCB and dioxin levels as high
as their mothers (adults) (6).
According to LaKind and Filser, the high
TCDD tissue concentration after 6 months
ofbreast-feeding does not give an increased
lifetime value for TCDD body burden. This
still needs to be investigated more thorough-
ly. Model calculations presented by Ayotte
(7) show that body burden in breast-fed
infants are relevant for the childhood years,
but not for periods beyond 20-30 years of
age. However, Smith (8) suggested that an
infant breast-fed for 12 months would
receive approximately 10% ofthe cumulative
exposure dose per bodyweight thatwould be
received by an adult with 50 years ofexpo-
sure. During childhood, the body burden is
raised by lactational PCB/dioxin exposure
(3,6). At 25 years of age, the PCB/dioxin
body burden could be higher due to breast-
feeding for 6 months. We reported (1) that 6
months ofbreast-feeding contributes to over
10% of the cumulative dietary intake until
25 years ofage. This amount ofPCB/dioxin
intake during 6 months ofbreast-feeding is
not negligible and certainly will not result in
misleading perceptions about health risk
assessment. In this paper (1), we tried to give
more quantitative information about the
dietary intake and several bodyburden calcu-
lations. We want to emphasize that although
PCB/dioxin accumulation in the infant's
body is a disadvantage, there are numerous
advantages ofbreast-feeding on the general
development ofinfants; therefore, we do not
encourage shortening the lactation period in
the general population (1,9).
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An Epidemic of Complex
Dysmorphologic Syndromes
in Southeast Spain?
I am a pediatrician at the Poniente
Regional Hospital in El Ejido (Almeria),
Spain. This hospital, which opened in
1995, offers specialized health care to the
150,000 inhabitants residing in El
Poniente, a Mediterranean coast area locat-
ed in the southeast of Spain. In the last 4
months I have diagnosed two newborns
from this area who are affected by extreme-
ly rare dysmorphologic syndromes: a) a
velocardiofacial syndrome and b) a complex
polymalformation including facial dysmor-
phy and polysyndactilia in hands and feet
associated with 2/8 translocation; neither
child had familiar antecedents. Surprised by
this uncommon geographical and temporal
cluster (in the Poniente area there are only
2,000 newborns/year), I reexamined the cases
ofnewborns affected by rare dysmorphologic
syndromes that I previously diagnosed in this
area. Some ofthese cases have been published
(1-6) because each case involves a very rare
disease. Below, I describe 11 cases (including
the two cases described above):
* Four cases with velocardiofacial syn-
drome, which were diagnosed in the
preceeding 5 years. After reviewing the
international literature (via Medline;
National Library of Medicine, Bethesda,
MD), I only found 100 cases described in
the world.
* Two cases ofJarcho-Levin syndrome
(from a whole of 73 recorded in the
reviewed literature).
* One case with 1 lq(-) syndrome (there
are only 30 well-documented cases in the
world).
* One case with 18qsyndrome (< 100 cases
described). Our case was also associated
with a familiar genetic abnormality (trans
1-18 in both the mother and thesister).
* One case of atypical Klinefelter syn-
drome (48XXYY) (only 74 cases found in
the literature).
* One case with cerebral-rib-mandible
syndrome, which includes multiple verte-
bral and rib defects, micrognathia, glos-
soptosis, palatal anomalies, and slow phys-
ical and psychomotorgrowth.
* One case of translocation (t 2:8 q32-
q21), which was mentioned above.
Assuming that no population-based inci-
dence data are available, I think that this
case-series constitutes an unusual geographic
(the Poniente area) and temporal (the last 10
years) clustering ofextremely scarce dysmor-
phologic syndromes that cannot be
explained only by chance. Environmental
factors may account for the observed aggre-
gation. The teratogenic and mutagenic
effects of some chemicals have been recog-
nized foryears. People living in the Poniente
area are highly exposed to pesticides because
ofintensive farming activities. There are two
main reasons to drawspecial attention to the
etiologic role ofagrochemical exposure.
First, there is an extremely high exposure
rate to these substances in our area. Since the
1960s, intensive agriculture in greenhouses
has expanded in southern Spain, close to the
Mediterranean Sea. Approximately 40,000
hectares ofplastic greenhouses are now locat-
ed in the Poniente area, which represents the
largest area devoted to this type offarming in
Europe (7). This intensive cultivation is pro-
tected against pests by the use of large
amounts ofpesticides, frequently used with-
out the basic required safety measures.
Moreover, acute intoxication by pesticides is
one of the most well-documented health
problems in our area. In addition, exposure
to agrochemicals in women working in
intensive agriculture presents a special situa-
tion because bioaccumulated pesticides can
be mobilized during pregnancyand lactation.
Second, the endocrine-disrupting effects
of pesticides in several animal species has
been well documented (8). Some hypotheses
suggest that this effect may also extend to
humans (9). Because the exposure to these
substances in the Poniente area is very high,
the implications of their effects on human
health is a matter ofgreat concern. But this
is not a local problem because pesticides are
commonly used all over theworld.
It is urgent that we investigate the pos-
sible causal links between pesticides and
health effects, particularly those affecting
human reproduction and embrionic and
fetal development. Are similar dysmorpho-
logic syndromes being observed in other
farming areas? Pesticide use and human
exposure is aworldwide matter.
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